Nanox Imaging is trading 5% down at $0.73, extending a seven-session decline from $0.86 on August 25, 2026.

  • No fresh company-specific announcement or clearly reported catalyst was identified for September 3, 2026. The next scheduled earnings report is September 9; the August 7 financing and August 18 UK reseller agreement predate the move.
  • Healthcare gained 1.37% and broader markets were strong, so sector or global sentiment does not clearly explain the decline; volume and activity details were unavailable.